Artivion Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced the successful closing of transactions to exchange approximately $99.5 million in principal amount of its 4.250% Convertible Senior Notes due 2025 for common stock. The exchange agreements resulted in the issuance of 4,334,347 shares of the company's common stock to the note holders, significantly reducing Artivion's outstanding debt and enhancing its balance sheet flexibility. Alongside the exchange, the company made a cash payment of approximately $1.7 million for accrued and unpaid interest. The transaction, advised by J. Wood Capital Advisors LLC, marks an important milestone in Artivion's efforts to strengthen its financial position, leaving only $0.46 million in aggregate principal amount of the notes outstanding.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。